Humana executive awarded 9,945-share stock grant

Shetty Sanjay K reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Shetty Sanjay K reported acquisition or exercise transactions in this Form 4 filing.

Humana Inc. President, CenterWell Sanjay K. Shetty received a grant of 9,945 shares of Humana Common stock as compensation. The shares were awarded at a price of $0.0000 per share and increase his directly held common stock position to 22,088 shares.

The filing also shows he holds stock options giving the right to buy 6,572 Humana shares at $367.21 per share expiring on February 21, 2031, and 3,964 shares at $487.1602 per share expiring on April 1, 2030. His reported holdings include 18,763 restricted stock units that can settle into Humana common shares.

Insider Trade Summary

Grant/Award: 9,945 shares

Grant/Award 3 txns

Insider Shetty Sanjay K

Role President, CenterWell

Type	Security	Shares	Price	Value
Grant/Award	Humana Common	9,945	$0.00	$0.00
holding	Options	--	--	--
holding	Options	--	--	--

Holdings After Transaction: Humana Common — 22,088 shares (Direct); Options — 10,536 contracts (Direct)

Footnotes (3)

1. F1. Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 4/1/2023, vesting in three annual increments from 4/1/24 to 4/1/26.
2. F2. Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 2/21/2024, vesting in three annual increments from 2/21/25 to 2/21/27.
3. F3. Includes 18,763 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated and 2026 Stock Incentive Plan.

Key Figures

Stock grant: 9,945 shares Common shares held: 22,088 shares Options at $367.21: 6,572 underlying shares +2 more

5 metrics

Stock grant 9,945 shares Humana Common granted at $0.0000 per share on May 1, 2026

Common shares held 22,088 shares Direct Humana Common holdings following the reported grant

Options at $367.21 6,572 underlying shares Right to buy Humana Common, expiring February 21, 2031

Options at $487.1602 3,964 underlying shares Right to buy Humana Common, expiring April 1, 2030

Restricted stock units 18,763 RSUs Contingent right to one Humana Inc. common share per unit

Key Terms

restricted stock units, Incentive and Non-Qualified stock options, Rule 16b-3(d)(1)&(3), Stock Incentive Plan

4 terms

restricted stock units financial

"Includes 18,763 restricted stock units representing a contingent right to receive one share"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Incentive and Non-Qualified stock options financial

"Incentive and Non-Qualified stock options granted to reporting person on 4/1/2023"

Rule 16b-3(d)(1)&(3) regulatory

"exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated and 2026 Stock Incentive Plan"

Stock Incentive Plan financial

"Company's 2019 Amended & Restated and 2026 Stock Incentive Plan"

A stock incentive plan is a company program that gives employees or directors pieces of ownership or the right to buy shares over time, similar to receiving a bonus paid in company stock instead of cash. Investors pay attention because these plans align staff incentives with long‑term company performance but can also dilute existing shareholders and affect reported profits when grants are expensed, so they influence both ownership percentages and financial results.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Humana (HUM) executive Sanjay K. Shetty report in this Form 4?

He reported receiving a grant of 9,945 shares of Humana Common stock at $0.0000 per share, increasing his direct holdings to 22,088 shares. The filing also outlines existing stock option positions and restricted stock units tied to Humana shares.

Is the 9,945-share transaction for HUM an open-market purchase or a grant?

The 9,945-share transaction is a grant or award, not an open-market purchase. It is coded as a grant, award, or other acquisition at $0.0000 per share, indicating compensation-related stock rather than shares bought on the open market by the executive.

How many Humana (HUM) shares does Sanjay K. Shetty hold after this Form 4?

After the reported grant, he directly holds 22,088 shares of Humana Common stock. This total, according to the footnotes, includes 18,763 restricted stock units that represent a contingent right to receive one share of Humana Inc. common stock for each unit.

What stock option positions tied to HUM does Sanjay K. Shetty report?

He reports options linked to 6,572 Humana shares at a $367.21 exercise price expiring February 21, 2031, and options linked to 3,964 shares at a $487.1602 exercise price expiring April 1, 2030. These remain outstanding as rights to buy Humana Common stock.

What are the restricted stock units mentioned in the Humana (HUM) filing?

The filing notes 18,763 restricted stock units representing a contingent right to receive one Humana Inc. common share per unit. They are granted under the company’s 2019 Amended & Restated and 2026 Stock Incentive Plan and are exempt under Rule 16b-3(d)(1)&(3).

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/05/2026 - 01:30 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Shetty Sanjay K

(Last) (First) (Middle)

HUMANA INC.

101 E. MAIN STREET

(Street)

LOUISVILLE KENTUCKY 40202

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
HUMANA INC [ HUM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President, CenterWell

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Humana Common	05/01/2026		A		9,945	A	$0	22,088(3)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Options(1)	$487.1602							(1)	04/01/2030	Humana Common	3,964		3,964	D
Options(2)	$367.21							(2)	02/21/2031	Humana Common	6,572		6,572	D

Explanation of Responses:

1. Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 4/1/2023, vesting in three annual increments from 4/1/24 to 4/1/26.

2. Right to buy pursuant to Company's 2019 Amended & Restated Stock Incentive Plan. Incentive and Non-Qualified stock options granted to reporting person on 2/21/2024, vesting in three annual increments from 2/21/25 to 2/21/27.

3. Includes 18,763 restricted stock units representing a contingent right to receive one share of Humana Inc. common stock, exempt under Rule 16b-3(d)(1)&(3) under the Company's 2019 Amended & Restated and 2026 Stock Incentive Plan.

	Sanjay K. Shetty	05/05/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)